New search Hide text from Guidelines
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSThis group comprises preparations used in the treatment of neoplastic diseases, and immunomodulating agents.
Corticosteroids for systemic use, see H02.
L03 IMMUNOSTIMULANTS
Immunosuppressants, see L04A.
L03A IMMUNOSTIMULANTS
Levamisole, which also affects the immune response, is classified in P02CE.
L03AB Interferons
Peginterferon alfa-2b in combination with ribavirin and peginterferon alfa-2a in combination with ribavirin are classified in L03AB60 and L03AB61, respectively.
| The DDD for interferon alfa is based on the treatment of chronic active hepatitis B, whilst the DDD for interferon beta is based on the treatment of multiple sclerosis. The DDDs of interferon beta-1a is based on i.m. administration. |
| ATC code | Name | DDD | U | Adm.R | Note |
| L03AB01 | interferon alfa natural | 2 | MU | P | |
| L03AB02 | interferon beta natural | 33.33 | TU | P | |
| L03AB03 | interferon gamma | 40 | mcg | P | |
| L03AB04 | interferon alfa-2a | 2 | MU | P | |
| L03AB05 | interferon alfa-2b | 2 | MU | P | |
| L03AB06 | interferon alfa-n1 | 5 | MU | P | |
| L03AB07 | interferon beta-1a | 4.3 | mcg | P | |
| L03AB08 | interferon beta-1b | 4 | MU | P | |
| L03AB09 | interferon alfacon-1 | 4 | mcg | P | |
| L03AB10 | peginterferon alfa-2b | 7.5 | mcg | P | |
| L03AB11 | peginterferon alfa-2a | 26 | mcg | P | |
| L03AB12 | albinterferon alfa-2b | ||||
| L03AB13 | peginterferon beta-1a | 8.9 | mcg | P | |
| L03AB14 | cepeginterferon alfa-2b | 17 | mcg | P | |
| L03AB15 | ropeginterferon alfa-2b | ||||
| L03AB16 | peginterferon alfacon-2 | ||||
| L03AB17 | sampeginterferon beta-1a | ||||
| L03AB60 | peginterferon alfa-2b, combinations | ||||
| L03AB61 | peginterferon alfa-2a, combinations |
Last updated: 2024-01-26